SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005698
Filing Date
2020-05-07
Accepted
2020-05-07 16:09:01
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20200331x10q.htm 10-Q 1721753
2 EX-10.1 kala-20200331ex101d85630.htm EX-10.1 78230
3 EX-10.2 kala-20200331ex102d22ecb.htm EX-10.2 59151
4 EX-10.3 kala-20200331ex103acfde5.htm EX-10.3 61332
5 EX-31.1 kala-20200331ex3117ddf0b.htm EX-31.1 22009
6 EX-31.2 kala-20200331ex312f56a80.htm EX-31.2 21885
7 EX-32.1 kala-20200331ex321f2e68d.htm EX-32.1 10251
8 EX-32.2 kala-20200331ex322f3c102.htm EX-32.2 10670
  Complete submission text file 0001558370-20-005698.txt   5711492

Data Files

Seq Description Document Type Size
9 EX-101.INS kala-20200331.xml EX-101.INS 945087
10 EX-101.SCH kala-20200331.xsd EX-101.SCH 48379
11 EX-101.CAL kala-20200331_cal.xml EX-101.CAL 39916
12 EX-101.DEF kala-20200331_def.xml EX-101.DEF 158848
13 EX-101.LAB kala-20200331_lab.xml EX-101.LAB 372226
14 EX-101.PRE kala-20200331_pre.xml EX-101.PRE 298779
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 20856391
SIC: 2834 Pharmaceutical Preparations